Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.57 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.57 |
| ▸ | HTR2A | P28223 | 1/20 | 0.57 |
| ▸ | SCN1A | P35498 | 1/20 | 0.57 |
| ▸ | HTR2B | P41595 | 1/20 | 0.57 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.57 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.57 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.57 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21348421 | 0.96 | MAPK1 (0.54) | HRH3ALDH1A1MAPK1CYP1A2CHRM2 | |
| SCHEMBL10922490 | 0.94 | ALDH1A1 (0.55) | HRH3ALDH1A1MAPK1CYP1A2CHRM2 | |
| SCHEMBL474810 | 0.92 | ALDH1A1 (0.51) | HRH3ALDH1A1MAPK1CYP1A2CHRM2 | |
| Bromide SCHEMBL2354924 | 0.90 | ALDH1A1 (0.50) | HRH3ALDH1A1MAPK1CYP1A2CHRM2 | |
| SCHEMBL14524633 | 0.90 | ALDH1A1 (0.50) | HRH3ALDH1A1MAPK1CYP1A2CHRM2 | |
| SCHEMBL3299959 | 0.88 | KDM4E (0.55) | HRH3ALDH1A1MAPK1CYP1A2CHRM2 | |
| SCHEMBL5293921 | 0.87 | KEAP1 (0.58) | HRH3ALDH1A1MAPK1CYP1A2CHRM2 | |
| SCHEMBL10928264 | 0.86 | ALDH1A1 (0.60) | HRH3ALDH1A1MAPK1CYP1A2CHRM2 | |
| SCHEMBL20333202 | 0.86 | HTT (0.52) | HRH3ALDH1A1MAPK1CYP1A2CHRM2 | |
| SCHEMBL11569854 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7468399-B2 | Antifouling condensation curing organopolysiloxane composition and underwater structure | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2008-12-23 | — | — | US | claimed |
| EP-1634928-B1 | Antifouling condensation curing organopolysiloxane composition and underwater structure | SHINETSU CHEMICAL CO (JP) | 2007-10-31 | — | — | EP | claimed |
| EP-3892701-B1 | UV CURABLE SILICONE ADHESIVE COMPOSITION AND CURED PRODUCT THEREOF | SHINETSU CHEMICAL CO (JP) | 2026-03-04 | — | — | EP | disclosed |
| US-20250287559-A1 | MICROSTRUCTURE-TRANSFER APPARATUS, STAMP HEAD UNIT, STAMP COMPONENT FOR TRANSFERRING MICROSTRUCTURE, AND METHOD FOR TRANSFERRING MICROSTRUCTURE-INTEGRATED COMPONENT | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-09-11 | — | — | US | disclosed |
| US-12342467-B2 | Microstructure-transfer apparatus, stamp head unit, stamp component for transferring microstructure, and method for transferring microstructure-integrated component | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-06-24 | — | — | US | disclosed |
| US-12168745-B2 | Ultraviolet ray curable silicone adhesive composition and cured product thereof | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-12-17 | — | — | US | disclosed |
| CN-115038767-B | Addition-curable silicone pressure-sensitive adhesive composition and cured product thereof | 信越化学工业株式会社 | 2024-07-26 | — | — | CN | disclosed |
| CN-113396485-B | Microstructure transferring device, template head unit, template member for microstructure transferring, and method for transferring microstructure integrated member | 信越化学工业株式会社 | 2024-07-26 | — | — | CN | disclosed |
| CN-118352439-A | Microstructure transferring device, template head unit, template member for microstructure transferring, and method for transferring microstructure integrated member | 信越化学工业株式会社 | 2024-07-16 | — | — | CN | disclosed |
| US-20240226113-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | KUMQUAT BIOSCIENCES INC. | 2024-07-11 | — | — | US | disclosed |
| EP-3885420-B1 | ULTRAVIOLET RAY CURABLE SILICONE ADHESIVE COMPOSITION AND CURED PRODUCT THEREOF | SHINETSU CHEMICAL CO (JP) | 2023-11-29 | — | — | EP | disclosed |
| US-7468399-B2 | Antifouling condensation curing organopolysiloxane composition and underwater structure | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2008-12-23 | — | — | US | disclosed |
| US-20080293712-A1 | Benzo[C][2,7]Naphtyridine Derivatives, Methods of Making Thereof and Methods of Use Thereof | WYETH (US) | 2008-11-27 | — | — | US | disclosed |
| US-7326790-B2 | Diphenylisoxazole compounds and hydro isomers thereof | RIGEL PHARMACEUTICALS, INC. (US) | 2008-02-05 | — | — | US | disclosed |
| US-20080004273-A1 | Inhibitors of protein tyrosine kinase activity | METHYLGENE, INC. (CA) | 2008-01-03 | — | — | US | disclosed |
| EP-1634928-B1 | Antifouling condensation curing organopolysiloxane composition and underwater structure | SHINETSU CHEMICAL CO (JP) | 2007-10-31 | — | — | EP | disclosed |
| US-7220745-B2 | Heterocyclic compounds useful to treat HCV | RIGEL PHARMACEUTICALS (US) | 2007-05-22 | — | — | US | disclosed |
| US-20060058452-A1 | Antifouling condensation curing organopolysiloxane composition and underwater structure | SHIN-ETSU CHEMICAL CO., LTD. | 2006-03-16 | — | — | US | disclosed |
| EP-1634928-A1 | Antifouling condensation curing organopolysiloxane composition and underwater structure | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2006-03-15 | — | — | EP | disclosed |
| WO-2004052847-A2 | TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS | ELI LILLY AND COMPANY (US) | 2004-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240226113-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | TP53, HRAS, KRAS | HRH3 2868/4885ALDH1A1 2917/4885MAPK1 416/4885 |
| US-20080004273-A1 | Inhibitors of protein tyrosine kinase activity | HGF, ERBB2, MET | HRH3 2228/4885ALDH1A1 3139/4885MAPK1 168/4885 |
| US-20080293712-A1 | Benzo[C][2,7]Naphtyridine Derivatives, Methods of Making Thereof and Methods of Use Thereof | PDPK1, PDK2, PDK3 | HRH3 949/4885ALDH1A1 2573/4885MAPK1 168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.